Skip to main content

Computationally Informed Insights Into Anhedonia and Treatment by Kappa Opioid Receptor Antagonism.

Publication ,  Journal Article
Bari, BA; Krystal, AD; Pizzagalli, DA; Gershman, SJ
Published in: Biol Psychiatry Cogn Neurosci Neuroimaging
November 2025

BACKGROUND: Anhedonia, the loss of pleasure, is prevalent and impairing. Parsing its computational basis promises to explain its transdiagnostic character. One manifestation of anhedonia, reward insensitivity, may be linked to limited memory. Furthermore, the need to economize on limited memory engenders a perseverative bias toward frequently chosen actions. Anhedonia may also be linked with deviations from optimal perseveration for a given memory capacity, a pattern that causes inefficiency because it results in less reward for the same memory cost. METHODS: To test these hypotheses, we applied a theory of optimal decision making under memory constraints that decomposes behavior into a memory component and an efficiency component. We applied this theory to behavior on the Probabilistic Reward Task, a reward learning paradigm that has been validated in anhedonia, and performed secondary analysis of a randomized controlled trial testing kappa opioid receptor (KOR) antagonism for anhedonia (n = 24 KOR; n = 31 placebo), as well as analyses of 3 other datasets (n = 100, 66, 24, respectively). We fit a resource-bounded reinforcement learning model to behavior. RESULTS: Across clinical and nonclinical populations, anhedonia was associated with deficits in efficiency but not memory. The reinforcement learning models demonstrated that deficits in efficiency arise from the inability to perseverate optimally. KOR antagonism, which likely elevates tonic dopamine, increases both memory and efficiency, and the model demonstrated that this arises from increased reward sensitivity and perseveration. CONCLUSIONS: Therefore, KOR antagonism has distinct cognitive effects, only one related to anhedonia. These findings have potential implications for the applications of KOR antagonists.

Duke Scholars

Published In

Biol Psychiatry Cogn Neurosci Neuroimaging

DOI

EISSN

2451-9030

Publication Date

November 2025

Volume

10

Issue

11

Start / End Page

1177 / 1185

Location

United States

Related Subject Headings

  • Young Adult
  • Reward
  • Reinforcement, Psychology
  • Receptors, Opioid, kappa
  • Narcotic Antagonists
  • Middle Aged
  • Memory
  • Male
  • Humans
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Bari, B. A., Krystal, A. D., Pizzagalli, D. A., & Gershman, S. J. (2025). Computationally Informed Insights Into Anhedonia and Treatment by Kappa Opioid Receptor Antagonism. Biol Psychiatry Cogn Neurosci Neuroimaging, 10(11), 1177–1185. https://doi.org/10.1016/j.bpsc.2025.05.011
Bari, Bilal A., Andrew D. Krystal, Diego A. Pizzagalli, and Samuel J. Gershman. “Computationally Informed Insights Into Anhedonia and Treatment by Kappa Opioid Receptor Antagonism.Biol Psychiatry Cogn Neurosci Neuroimaging 10, no. 11 (November 2025): 1177–85. https://doi.org/10.1016/j.bpsc.2025.05.011.
Bari BA, Krystal AD, Pizzagalli DA, Gershman SJ. Computationally Informed Insights Into Anhedonia and Treatment by Kappa Opioid Receptor Antagonism. Biol Psychiatry Cogn Neurosci Neuroimaging. 2025 Nov;10(11):1177–85.
Bari, Bilal A., et al. “Computationally Informed Insights Into Anhedonia and Treatment by Kappa Opioid Receptor Antagonism.Biol Psychiatry Cogn Neurosci Neuroimaging, vol. 10, no. 11, Nov. 2025, pp. 1177–85. Pubmed, doi:10.1016/j.bpsc.2025.05.011.
Bari BA, Krystal AD, Pizzagalli DA, Gershman SJ. Computationally Informed Insights Into Anhedonia and Treatment by Kappa Opioid Receptor Antagonism. Biol Psychiatry Cogn Neurosci Neuroimaging. 2025 Nov;10(11):1177–1185.

Published In

Biol Psychiatry Cogn Neurosci Neuroimaging

DOI

EISSN

2451-9030

Publication Date

November 2025

Volume

10

Issue

11

Start / End Page

1177 / 1185

Location

United States

Related Subject Headings

  • Young Adult
  • Reward
  • Reinforcement, Psychology
  • Receptors, Opioid, kappa
  • Narcotic Antagonists
  • Middle Aged
  • Memory
  • Male
  • Humans
  • Female